Real-world treatment in patients with HER2+ metastatic breast cancer: Treatment decisions in HER2+ mBC

PURPOSE: The landscape of HER2+ metastatic breast cancer (mBC) treatment is changing due to the availability of new anti-HER2 drugs. The purpose of this study was to assess the current treatment patterns and sequences used in HER2+ mBC in the real-world setting. Secondary objectives were to describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Colomer, R., Hall, P., Szkultecka-Debek, M., Bondi, R. C., Flinois, A., Auziere, S., Le Cléac’h, J. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847072/
https://www.ncbi.nlm.nih.gov/pubmed/29170976
http://dx.doi.org/10.1007/s10549-017-4567-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847072/
https://www.ncbi.nlm.nih.gov/pubmed/29170976
http://dx.doi.org/10.1007/s10549-017-4567-z

Ejemplares similares